- ☰
- Add title
- Add keywords
- Add publication
- Leave comment
Glycosciences.DB structure entry #766:
b-D-Galp-(1-3)-b-D-GalpNAc-(1-4)+
|
b-D-Galp-(1-4)-b-D-Glcp-(1-1)-sphingosine-(2-1)-<2-chloroacetate>
|
a-D-Neup5Ac-(2-3)+
[][<2-CHLOROACETATE>]{[(1+2)][SPHINGOSINE]{[(1+1)][B-D-GLCP]{[(4+1)][B-D-GALP]{[(3+2)][A-D-NEUP5AC]{}[(4+1)][B-D-GALPNAC]{[(3+1)][B-D-GALP]{}}}}}}
1 - 5 of 22 entries with matching glycan part
Structure entry #142: Glycosphingolipid GM1 / GM1a
b-D-Galp-(1-3)-b-D-GalpNAc-(1-4)+
|
b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
|
a-D-Neup5Ac-(2-3)+
 |
 13C: 1 |
 : 1 |
 : 643 |
 |
Taxons: 20 |
Structure entry #765:
b-D-Galp-(1-3)-b-D-GalpNAc-(1-4)+
|
b-D-Galp-(1-4)-b-D-Glcp-(1-1)-<2-D-erythro-2-acetamide-octadec-4E-en-1,3-diol>
|
a-D-Neup5Ac-(2-3)+
|
 |
 |
: 2 |
|
Taxons |
Structure entry #2677:
b-D-Galp-(1-3)-b-D-GalpNAc-(1-4)+
|
b-D-Galp-(1-4)-b-D-Glcp
|
a-D-Neup5Ac-(2-3)+
 |
|
: 13 |
: 99 |
|
Taxons |
Structure entry #2875:
b-D-Galp-(1-3)-b-D-GalpNAc-(1-4)+
|
b-D-Galp-(1-4)-b-D-Glcp-(1-1)-hexyl
|
a-D-Neup5Ac-(2-3)+
|
|
|
: 1 |
|
Taxons |
Structure entry #3946:
b-D-Galp-(1-3)-b-D-GalpNAc-(1-4)+
|
b-D-Galp-(1-4)-b-D-Glcp-(1-1)-2R-amino-Octadec-4E-en-1,3S-diol
|
a-D-Neup5Ac-(2-3)+
|
|
|
: 6 |
|
Taxons: 1 |
- GM1a (Show) (Search Database)
- GSL core, ganglio-type (Show) (Search Database)
| Chemical Formula: | ||
| Molec. Weight: | ||
| # Atoms: | ||
| # Residues: | 7 | |
| # Heavy Atoms: | ||
Superclasses:
|
Residues:
|
||||||||||||||||||||||||||
Literature references: 51 - 5 of 5 literature references
Reference #12644
Schneider JS; Distefano L
Response of the damaged dopamine system to GM1 and semisynthetic gangliosides: Effects of dose and extent of lesion
Published 1995 in Neuropharmacology, 34: 489-493
Reference contains 2 structures
Reference #12434
Polo A; Kirschner G; Guidotti A; Costa E
Brain content of glycosphingolipids after oral administration of monosialogangliosides GM1 and LIGA20 to rats
Published 1994 in Mol Chem Neuropathol, 21: 41-53
Reference contains 2 structures
Reference #12634
Schneider JS; DiStefano L
Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism
Published 1994 in Neurology, 44: 748-750
Reference contains 3 structures
Reference #127
Manev H; Guidotti A; Costa E
Protection by gangliosides against excitotoxicity
Published 1993 in Adv Lipid Res, 25: 269-288
Reference contains 5 structures
Reference #12648
Schneider JS; DiStefano L
LIGA 20 increases striatal dopamine levels in aged MPTP-treated mice refractory to GM1 ganglioside treatment
Published 1993 in Neuroreport, 5: 103-104
Reference contains 2 structures
×
Add title to glycan structure entry:
×
Add keyword to glycan structure entry:
×
Add publication to glycan structure entry:
×